Does Buprenorphine Show Up on a Drug Test?

Evidence-based answer reviewed against SAMHSA cutoffs and FDA assay documentation · Updated August 2026

Quick answer: No — not on any standard panel. Buprenorphine is absent from routine 5-, 10-, and 12-panel employment drug tests. Specialized/expanded urine assays at ~5 ng/mL (buprenorphine or norbuprenorphine) — far below standard opiate cutoffs.

Which panels screen for it

PanelBuprenorphine status
5-Panel❌ Not included
10-Panel✅ On expanded cups
12-Panel✅ Included
DOT 5-panel (safety-sensitive)❌ Not included

The details that matter

Standard opiate screens miss buprenorphine entirely — its structure differs enough from morphine/codeine that 2,000 ng/mL opiate assays don't see it. Labs must order a dedicated buprenorphine assay (commonly part of 12-panel-plus or addiction-medicine panels).

Treatment-program and pain-clinic panels almost always include BUP specifically because they prescribe it. Employment panels less commonly do, though many 12-panel cups now carry it.

A valid buprenorphine prescription verifies as negative-with-explanation through the MRO. ADA considerations may apply when employers treat MAT patients adversely — document everything.

Norbuprenorphine (the metabolite) outlasts the parent drug; labs may target either.

If it IS detected, how long does it last?

Ranges reflect occasional-to-heavy use patterns from FDA device inserts and SAMHSA-certified lab conventions.
Test typeTypical Buprenorphine detection window
Urineoccasional: 3–6 days · regular: up to 14 days at higher chronic doses
Saliva (Mouth Swab)any: 1–4 days on specialized assays
Hair Folliclesup to 90 days (specialized)
Bloodany: ~2–4 days

False-positive notes

  • No common medication produces buprenorphine false positives; the dedicated assay is highly specific.

Remember: immunoassay screens produce artifacts; mass-spec confirmation and the MRO review are where legitimate explanations win.

Certified labs nationwide · Results in 1–2 days

Need a test? Order online, test same-day →
Medical disclaimer: DrugPanels provides educational information about laboratory drug testing and does not offer medical advice, diagnosis, or treatment. Detection windows are population ranges — individual results vary with metabolism, dose, frequency and health status. Never stop prescribed medication to pass a test without talking to your prescriber. Affiliate disclosure: some links on this page are affiliate links; if you order through them we may earn a commission at no additional cost to you.

People also ask

Does buprenorphine Show up on a Drug Test?

No — Buprenorphine is absent from standard drug panels. Full guide →

How Long Does buprenorphine Show up in a Drug Test?

How long Buprenorphine stays detectable in your system (all test types) — urine, hair, saliva & blood windows explained with cutoffs. Full guide →

What Can Cause a False Positive Drug Test for buprenorphine?

Can Buprenorphine trigger a false positive? Cross-reactivity evidence, confirmation testing, and how to clear your name with the MRO. Full guide →

How Can You Pass a Drug Test for buprenorphine?

Evidence-based ways to pass a drug test for Buprenorphine — realistic timelines, what works, what backfires, and dilution flags to avoid. Full guide →

Does buprenorphine Show up on a Drug Test?

No — standard employment panels don't include Buprenorphine. Only specialized orders reach it.

Would buprenorphine Show up on a Drug Test?

No — standard employment panels don't include Buprenorphine. Only specialized orders reach it.

How accurate are drug tests?

Lab-based immunoassay screens agree with confirmation testing ~97% of the time; confirmed GC–MS results are considered definitive. Home kits trade legal defensibility for convenience.

Do prescriptions count against me?

No — verified prescriptions report as negative through the Medical Review Officer. Declare medications at collection and answer the follow-up call.

Sources & further reading

  • SAMHSA — Mandatory Guidelines for Federal Workplace Drug Testing Programs (cutoffs, MRO process)
  • DOT — 49 CFR Part 40 procedures for transportation workplace testing
  • Brahm NC et al., Mayo Clinic Proceedings 2008;83(1):66–76 — false-positive cross-reactivity reference
  • FDA — drug-of-abuse test device labeling (detection window conventions)